Feedback / Questions
surabgene lomparvovec (ABBV-RGX-314) - REGENXBIO, AbbVie
ixoberogene soroparvovec (ADVM-022) - Adverum Biotech
Lucentis (ranibizumab) - Roche, Novartis
http://www.ncbi.nlm.nih.gov/pubmed/40293479
Erika Quesada; Lihteh Wu; Sofía Rojas; Xiomara Campos
Apr 28, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next